Fluvoxamine was approved for the treatment of Covid-19 in Ontario, Canada on December 20, 2021. Here are the treatment guidelines along with warnings concerning drug interactions and side effects. https://covid19-sciencetable.ca/wp-content/uploads/2022/01/Fluvoxamine-What-prescribers-and-pharmacists-need-to-know_20220112-1.pdf
Fluvoxamine was approved for the treatment of Covid-19 in Ontario, Canada on December 20, 2021. Here are the treatment guidelines along with warnings concerning drug interactions and side effects. https://covid19-sciencetable.ca/wp-content/uploads/2022/01/Fluvoxamine-What-prescribers-and-pharmacists-need-to-know_20220112-1.pdf